HLYK · HealthLynked Corp
Substantial doubt about the company's ability to continue as a going concern.
“Without raising additional capital, there is substantial doubt about the Company’s ability to continue as a going concern through May 15, 2027.”View the 10-Q filed May 15, 2026
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.71M | $2.07M | $3.01M | $5.72M | $5.86M | $6.5M | $6.13M | $4.02M | $2.26M | $2.1M | — | |
| $2.95M | — | — | — | — | — | — | $2.92M | $2.84M | $1.85M | $1.54M | |
| $2.25M | $2.04M | $3.04M | $3.62M | $4.58M | $4.93M | $3.06M | $2.92M | — | — | — | |
| — | $0 | $167.85K | $228.16K | $715.8K | $715.8K | $145.87K | $5908 | $0 | — | — | |
| $99.89K | $101.87K | $282.95K | $352.03K | $829.48K | $827.7K | $247.37K | $73.39K | $23.78K | $23.61K | $16.46K | |
| $3.91M | $4.18M | $7.69M | $9.87M | $14.52M | $11.83M | $9.2M | $7.23M | $5.23M | $3.89M | $3.12M | |
| -$2.2M | -$2.11M | -$4.68M | -$4.15M | -$8.66M | -$5.33M | -$3.07M | -$3.21M | -$2.97M | -$1.79M | -$1.17M | |
| — | -102.32% | -155.49% | -72.55% | -147.82% | -82.05% | -50.09% | -79.85% | -131.57% | -85.16% | — | |
| -$2.1M | -$2.01M | -$4.39M | -$3.8M | -$7.83M | -$4.5M | -$2.82M | -$3.14M | -$2.95M | -$1.77M | -$1.16M | |
| — | — | — | $21.33K | $0 | — | — | $244.09K | $193.11K | $99.67K | $36.63K | |
| -$1.65M | -$1.17M | -$1.45M | $537.76K | $591.89K | -$19.14K | -$2.68M | -$2.32M | -$2.82M | -$789.67K | -$202.02K | |
| — | -$3.28M | -$6.13M | -$1.01M | -$8.82M | — | — | — | — | — | — | |
| — | — | — | — | — | — | -$282.11K | — | — | — | — | |
| — | — | -$6.13M | -$3.61M | -$8.07M | -$10.7M | -$5.76M | -$5.53M | -$5.79M | -$2.58M | -$1.38M | |
| -$3.85M | -$3.28M | -$6.13M | -$1.01M | -$8.82M | -$10.41M | -$5.76M | -$5.53M | -$5.79M | -$2.58M | -$1.38M | |
| — | -158.83% | -203.81% | -17.69% | -150.49% | -160.26% | -93.84% | -137.57% | -256.34% | -122.7% | — | |
| — | — | — | -$1.01M | -$9.17M | -$10.77M | -$6.2M | -$5.53M | — | — | — | |
| USD/shares | — | -$1.16 | -$2.18 | $0.00 | -$4.00 | -$5.00 | -$4.00 | -$6.00 | -$7.00 | -$4.00 | -$2.00 |
| USD/shares | — | -$1.16 | -$2.18 | $0.00 | -$4.00 | -$5.00 | -$4.00 | -$6.00 | -$7.00 | -$4.00 | -$2.00 |
| shares | — | 2.84M | 2.82M | 2.63M | 2.43M | 2.25M | 1.43M | 990.6K | 788.16K | 695.6K | 600.34K |
| shares | — | 2.84M | 2.82M | 2.63M | 2.43M | 2.25M | 1.43M | 990.6K | 788.16K | 695.6K | 600.34K |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2019–FY2021: $8900 in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 14 similar-size Medical Care Facilities companies (of 57 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Health Services | $2,002,548 | $2,872,177 | $5,484,278 | $5,407,416 | $5,764,186 | $4,743,811 |
| Medical Distribution | $40,121 | $103,759 | $179,200 | $429,951 | $6,497,131 | $188,588 |
| Digital Healthcare | $22,623 | $32,425 | $58,901 | $20,835 | $14,883 | — |
| ACOMCO | — | — | — | — | $718,062 | $1,200,721 |
| Total | — | — | — | — | $9,197,992 | — |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Patent Service Revenue Net | $2,002,548 | $2,872,177 | $5,484,278 | — |
| Product and Other Revenue | $40,121 | $103,759 | $179,200 | $429,951 |
| Subscription and Event Revenue | $22,623 | $32,425 | $58,901 | $20,835 |
| Patient Service Revenue Net | — | — | — | $5,407,416 |
| Product Revenue | — | — | — | $429,951 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Medical Distribution | -$39,118 | -$57,284 | -$65,892 | -$3,652,307 | -$5,331,024 | -$141,433 |
| Health Services | -$84,218 | -$1,673,575 | -$618,257 | -$610,474 | $190,227 | -$94,129 |
| Digital Healthcare | -$1,989,918 | -$2,946,789 | -$3,467,562 | -$4,396,593 | -$4,671,132 | -$3,019,494 |
| ACOMCO | — | — | — | — | -$850,119 | $183,227 |
| Total | — | — | — | — | -$5,043,368 | -$3,071,829 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Health Services | -4.2% | -58.3% | -11.3% | -11.3% | 3.3% | -2% |
| Medical Distribution | -97.5% | -55.2% | -36.8% | -849.5% | -82.1% | -75% |
| Digital Healthcare | -8796% | -9088% | -5887.1% | -21102% | -31385.7% | — |
| ACOMCO | — | — | — | — | -118.4% | 15.3% |
| Total | — | — | — | — | -54.8% | — |